Oseltamivir Dosing for a 26.3 kg Five-Year-Old Child
For a 5-year-old child weighing 26.3 kg, administer 60 mg of oseltamivir twice daily for treatment (or 60 mg once daily for prophylaxis), which equals 10 mL of the 6 mg/mL oral suspension per dose.
Weight-Based Dosing Algorithm
At 26.3 kg (approximately 58 lbs), this child falls into the >23 kg to 40 kg weight band according to current AAP and FDA guidelines 1, 2.
Treatment Dosing (5 days):
- Dose: 60 mg twice daily
- Volume: 10 mL of 6 mg/mL suspension per dose
- Frequency: Every 12 hours
- Duration: 5 days
- Dispensing: 2 bottles of oral suspension needed
Prophylaxis Dosing (7-10 days):
- Dose: 60 mg once daily
- Volume: 10 mL of 6 mg/mL suspension per dose
- Duration: 7 days (AAP/CDC recommendation) or 10 days (FDA labeling) 1
Key Clinical Considerations
Timing is critical: Treatment should begin within 48 hours of symptom onset for maximum benefit 2. The efficacy of oseltamivir when started after 48 hours has not been established.
Administration tips:
- May be given with or without food, though administration with meals may reduce gastrointestinal side effects 1, 2
- Can be administered via feeding tube if needed 1
- Use the 10 mL oral dosing dispenser provided with the suspension 1
Common Pitfalls to Avoid
Wrong concentration: Older guidelines from 2010 referenced a 12 mg/mL concentration 3. Current formulations are standardized at 6 mg/mL 4, 1, 5, 2. Using outdated references could result in underdosing by 50%.
Incorrect weight band: At 26.3 kg, this child is clearly above the 23 kg threshold. Do not use the 45 mg dose (which is for 16-23 kg children).
Renal function: If this child has renal insufficiency (creatinine clearance 10-30 mL/min), dose adjustment is required: reduce to 60 mg once daily for treatment 1.
Evidence Strength
These recommendations are based on FDA-approved labeling 2 and the most recent AAP guidelines from 2024-2025 1, which represent the highest quality guidance available. The weight-based dosing strategy is supported by pharmacokinetic studies demonstrating that children eliminate oseltamivir carboxylate faster than adults, necessitating weight-adjusted dosing to achieve therapeutic drug exposures 6, 7.
The 60 mg twice daily dose for this weight range has been validated to produce drug exposures within the range associated with tolerability and efficacy in adults 6.